Institutional investors purchased a net $3.5 million shares of IOVA during the quarter ended June 2019 and now own 101.05% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARK INVESTMENT MANAGEMENT LLC Bought 7.4 Million shares of Iovance Biotherapeutics I...